PDF herunterladen
Semin Reprod Med 2022; 40(01/02): 023-031
DOI: 10.1055/s-0041-1739309
Review Article

Heavy Menstrual Bleeding in Adolescent: Normal or a Sign of an Underlying Disease?

Kaisu Luiro 
1   Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland
,
Elina Holopainen 
1   Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Heavy, and often irregular, menstrual bleeding (HMB) is a common gynecologic complaint among adolescents. During the first few post-menarcheal years, anovulatory cycles related to immaturity of the hypothalamic–pituitary–ovarian axis are the most common etiology for abnormal uterine bleeding and should be considered as a part of normal pubertal development rather than a disease. If an already regular menstrual cycle becomes irregular, secondary causes of anovulation should be ruled out. Inherited and acquired bleeding disorders, such as von Willebrand disease, and quantitative and qualitative abnormalities of platelets are relatively common findings in adolescents with HMB from menarche. History of excessive bleeding or a diagnosed bleeding disorder in the family supports this etiology, warranting specialized laboratory testing. First-line treatment of HMB among adolescents is medical management with hormonal therapy or nonhormonal options. Levonorgestrel-releasing intrauterine device is an effective tool also for all adolescents with menstrual needs.

Keywords

adolescent - menorrhagia - anovulation - von Willebrand disease - hormonal treatment


Publikationsverlauf

Artikel online veröffentlicht:
03. November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Munro MG, Critchley HOD, Fraser IS. FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet 2018; 143 (03) 393-408
    CrossrefPubMedGoogle Scholar
  • 2 ACOG Committee Opinion No. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 2015; 126 (06) e143-e146
    CrossrefPubMedGoogle Scholar
  • 3 Friberg B, Ornö AK, Lindgren A, Lethagen S. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand 2006; 85 (02) 200-206
    CrossrefPubMedGoogle Scholar
  • 4 Powers JM, Stanek JR, Srivaths L, Haamid FW, O'Brien SH. Hematologic considerations and management of adolescent girls with heavy menstrual bleeding and anemia in US children's hospitals. J Pediatr Adolesc Gynecol 2018; 31 (05) 446-450
    CrossrefPubMedGoogle Scholar
  • 5 Wang W, Bourgeois T, Klima J, Berlan ED, Fischer AN, O'Brien SH. Iron deficiency and fatigue in adolescent females with heavy menstrual bleeding. Haemophilia 2013; 19 (02) 225-230
    CrossrefPubMedGoogle Scholar
  • 6 Zia A, Rajpurkar M. Challenges of diagnosing and managing the adolescent with heavy menstrual bleeding. Thromb Res 2016; 143: 91-100
    CrossrefPubMedGoogle Scholar
  • 7 International Federation of Pediatric and Adolescent Gynecology (FIGIJ). Advocacy Statement on Global Menstrual Health. Published 2021. Accessed September 30, 2021 at: https://www.figij.org/figij-advocacy-statement-menstrual-health-globally/
    PubMedGoogle Scholar
  • 8 Young J, Xu C, Papadakis GE. et al. Clinical management of congenital hypogonadotropic hypogonadism. Endocr Rev 2019; 40 (02) 669-710
    CrossrefPubMedGoogle Scholar
  • 9 Ruohonen ST, Poutanen M, Tena-Sempere M. Role of kisspeptins in the control of the hypothalamic-pituitary-ovarian axis: old dogmas and new challenges. Fertil Steril 2020; 114 (03) 465-474
    CrossrefPubMedGoogle Scholar
  • 10 Sørensen K, Mouritsen A, Aksglaede L, Hagen CP, Mogensen SS, Juul A. Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm Res Paediatr 2012; 77 (03) 137-145
    CrossrefPubMedGoogle Scholar
  • 11 Aksglaede L, Sørensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 2009; 123 (05) e932-e939
    CrossrefPubMedGoogle Scholar
  • 12 Chumlea WC, Schubert CM, Roche AF. et al. Age at menarche and racial comparisons in US girls. Pediatrics 2003; 111 (01) 110-113
    CrossrefPubMedGoogle Scholar
  • 13 Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem 1984; 20 (01) 231-236
    CrossrefPubMedGoogle Scholar
  • 14 Rodeghiero F, Tosetto A, Abshire T. et al; ISTH/SSC Joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8 (09) 2063-2065
    Google Scholar
  • 15 Elbatarny M, Mollah S, Grabell J. et al; Zimmerman Program Investigators. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia 2014; 20 (06) 831-835
    CrossrefPubMedGoogle Scholar
  • 16 O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology (Am Soc Hematol Educ Program) 2018; 2018 (01) 390-398
    CrossrefPubMedGoogle Scholar
  • 17 James AH. Bleeding disorders in adolescents. Obstet Gynecol Clin North Am 2009; 36 (01) 153-162
    CrossrefPubMedGoogle Scholar
  • 18 Alaqzam TS, Stanley AC, Simpson PM, Flood VH, Menon S. Treatment modalities in adolescents who present with heavy menstrual bleeding. J Pediatr Adolesc Gynecol 2018; 31 (05) 451-458
    CrossrefPubMedGoogle Scholar
  • 19 Flug D, Largo RH, Prader A. Menstrual patterns in adolescent Swiss girls: a longitudinal study. Ann Hum Biol 1984; 11 (06) 495-508
    CrossrefPubMedGoogle Scholar
  • 20 Giviziez CR, Sanchez EGM, Approbato MS, Maia MCS, Fleury EAB, Sasaki RSA. Obesity and anovulatory infertility: a review. JBRA Assist Reprod 2016; 20 (04) 240-245
    CrossrefPubMedGoogle Scholar
  • 21 Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351 (9101): 485-489
    CrossrefPubMedGoogle Scholar
  • 22 Vo KT, Grooms L, Klima J, Holland-Hall C, O'Brien SH. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia 2013; 19 (01) 71-75
    CrossrefPubMedGoogle Scholar
  • 23 James AH. Women and bleeding disorders. Haemophilia 2010; 16 (Suppl. 05) 160-167
    CrossrefPubMedGoogle Scholar
  • 24 James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005; 11 (04) 295-307
    CrossrefPubMedGoogle Scholar
  • 25 Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015; 125 (13) 2052-2061
    CrossrefPubMedGoogle Scholar
  • 26 Neunert C, Terrell DR, Arnold DM. et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 2019; 3 (23) 3829-3866
    CrossrefPubMedGoogle Scholar
  • 27 Dilley A, Drews C, Miller C. et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001; 97 (04) 630-636
    PubMedGoogle Scholar
  • 28 Miller CH, Philipp CS, Stein SF. et al. The spectrum of haemostatic characteristics of women with unexplained menorrhagia. Haemophilia 2011; 17 (01) e223-e229
    CrossrefPubMedGoogle Scholar
  • 29 Mills HL, Abdel-Baki MS, Teruya J. et al. Platelet function defects in adolescents with heavy menstrual bleeding. Haemophilia 2014; 20 (02) 249-254
    CrossrefPubMedGoogle Scholar
  • 30 Borzutzky C, Jaffray J. Diagnosis and management of heavy menstrual bleeding and bleeding disorders in adolescents. JAMA Pediatr 2020; 174 (02) 186-194
    CrossrefPubMedGoogle Scholar
  • 31 Teede HJ, Misso ML, Costello MF. et al; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 2018; 33 (09) 1602-1618
    CrossrefPubMedGoogle Scholar
  • 32 Hernandez A, Dietrich JE. Abnormal uterine bleeding in the adolescent. Obstet Gynecol 2020; 135 (03) 615-621
    CrossrefPubMedGoogle Scholar
  • 33 Kendel NE, Haamid FW, Christian-Rancy M, O'Brien SH. Characterizing adolescents with heavy menstrual bleeding and generalized joint hypermobility. Pediatr Blood Cancer 2019; 66 (06) e27675
    CrossrefPubMedGoogle Scholar
  • 34 Kouides PA. Aspects of the laboratory identification of von Willebrand disease in women. Semin Thromb Hemost 2006; 32 (05) 480-484
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 35 Johnson S, Lang A, Sturm M, O'Brien SH. Iron deficiency without anemia: a common yet under-recognized diagnosis in young women with heavy menstrual bleeding. J Pediatr Adolesc Gynecol 2016; 29 (06) 628-631
    CrossrefPubMedGoogle Scholar
  • 36 Stimpson SJ, Rebele EC, DeBaun MR. Common gynecological challenges in adolescents with sickle cell disease. Expert Rev Hematol 2016; 9 (02) 187-196
    CrossrefPubMedGoogle Scholar
  • 37 Roberts JC, Flood VH. Laboratory diagnosis of von Willebrand disease. Int J Lab Hematol 2015; 37 (Suppl. 01) 11-17
    CrossrefPubMedGoogle Scholar
  • 38 Higgins RA, Goodwin AJ. Automated assays for von Willebrand factor activity. Am J Hematol 2019; 94 (04) 496-503
    CrossrefPubMedGoogle Scholar
  • 39 Dumont T, Allen L, Kives S. Can von Willebrand disease be investigated on combined hormonal contraceptives?. J Pediatr Adolesc Gynecol 2013; 26 (03) 138-141
    CrossrefPubMedGoogle Scholar
  • 40 Stoffel NU, Cercamondi CI, Brittenham G. et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol 2017; 4 (11) e524-e533
    CrossrefPubMedGoogle Scholar
  • 41 American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care. Options for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment: ACOG Committee Opinion, Number 817. Obstet Gynecol 2021; 137 (01) e7-e15
    CrossrefPubMedGoogle Scholar
  • 42 Committee Opinion No. 668 Summary: menstrual manipulation for adolescents with physical and developmental disabilities. Obstet Gynecol 2016; 128 (02) 418-419
    CrossrefPubMedGoogle Scholar
  • 43 Quint EH. Menstrual and reproductive issues in adolescents with physical and developmental disabilities. Obstet Gynecol 2014; 124 (2, Pt 1): 367-375
    CrossrefPubMedGoogle Scholar
  • 44 Pradhan S, Gomez-Lobo V. Hormonal contraceptives, intrauterine devices, gonadotropin-releasing hormone analogues and testosterone: menstrual suppression in special adolescent populations. J Pediatr Adolesc Gynecol 2019; 32 (5S): S23-S29
    CrossrefPubMedGoogle Scholar
  • 45 Galzote RM, Rafie S, Teal R, Mody SK. Transdermal delivery of combined hormonal contraception: a review of the current literature. Int J Womens Health 2017; 9: 315-321
    CrossrefPubMedGoogle Scholar
  • 46 European Medicines Agency—PRAC. Risk of Venous Thromboembolism with Combined Hormonal Contraceptives. 2013 . Accessed September 30, 2021 at: https://www.ema.europa.eu/en/documents/press-release/prac-confirms-benefits-all-combined-hormonal-contraceptives-chcs-continue-outweigh-risks_en.pdf
    PubMedGoogle Scholar
  • 47 Reimers A, Brodtkorb E, Sabers A. Interactions between hormonal contraception and antiepileptic drugs: clinical and mechanistic considerations. Seizure 2015; 28: 66-70
    CrossrefPubMedGoogle Scholar
  • 48 Chiusolo P, Salutari P, Sica S. et al. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation. Bone Marrow Transplant 1998; 21 (08) 821-823
    CrossrefPubMedGoogle Scholar
  • 49 Haamid F, Sass AE, Dietrich JE. Heavy menstrual bleeding in adolescents. J Pediatr Adolesc Gynecol 2017; 30 (03) 335-340
    CrossrefPubMedGoogle Scholar
  • 50 Sokkary N, Dietrich JE. Management of heavy menstrual bleeding in adolescents. Curr Opin Obstet Gynecol 2012; 24 (05) 275-280
    CrossrefPubMedGoogle Scholar
  • 51 ACOG Committee Opinion No. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol 2013; 121 (04) 891-896
    CrossrefPubMedGoogle Scholar
  • 52 Nichols WL, Hultin MB, James AH. et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14 (02) 171-232
    CrossrefPubMedGoogle Scholar
  • 53 Huvinen E, Holopainen E, Heikinheimo O. Norethisterone and its acetate - what's so special about them?. BMJ Sex Reprod Health 2021; 47 (02) 102-109
    CrossrefPubMedGoogle Scholar